Loading…

Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC–STBSG) recommendations for pathological examination and reporting

Abstract At present, there is not a commonly used and generally accepted standardized approach for the pathologic evaluation of pretreated soft tissue sarcomas. Also, it is still unclear whether the cut-off for prognostic relevance is similar in the many different histological subtypes of STS. This...

Full description

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) 2016-01, Vol.53, p.84-95
Main Authors: Wardelmann, E, Haas, R.L, Bovée, J.V.M.G, Terrier, Ph, Lazar, A, Messiou, C, LePechoux, C, Hartmann, W, Collin, F, Fisher, C, Mechtersheimer, G, DeiTos, A.P, Stacchiotti, S, Jones, R.L, Gronchi, A, Bonvalot, S
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract At present, there is not a commonly used and generally accepted standardized approach for the pathologic evaluation of pretreated soft tissue sarcomas. Also, it is still unclear whether the cut-off for prognostic relevance is similar in the many different histological subtypes of STS. This manuscript, produced by a European Organization for Research and Treatment of Cancer – Soft Tissue and Bone Sarcoma Group (EORTC–STBSG) endorsed task force, aims to propose standardization of the pathological examination process and the reporting of STS resection specimens after neoadjuvant radio- and/or chemotherapy.
ISSN:0959-8049
1879-0852
DOI:10.1016/j.ejca.2015.09.021